Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer

被引:26
作者
Zhang, DH
Wong, LL
Tai, LK
Koay, ESC
Hewitt, RE
机构
[1] Natl Univ Singapore, Dept Pathol, Singapore 119074, Singapore
[2] Natl Univ Singapore Hosp, Dept Lab Med, Mol Diag Ctr, Singapore 119074, Singapore
[3] Natl Univ Singapore, Oncol Res Inst, Singapore 117597, Singapore
关键词
metastasis suppressor; CC3; TIP30; HER-2; neu; breast cancer;
D O I
10.1007/s00432-005-0674-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The human CC3/TIP30 gene is a putative metastasis suppressor gene, based on the results of experimental studies using lung, colon and melanoma cell lines. However, there is very little evidence from studies on clinical material, in support of such a role for the gene. In this study, we evaluated the expression of CC3/TIP30 in human breast cancer tissue and investigated the possible associations with the clinicopathological parameters. Methods: Total RNA and proteins were extracted from the frozen breast tumor and matched normal tissues. Evaluation of CC3/TIP30 expression was assessed by reverse transcription (RT)-PCR and reverse phase protein array. Immunohistochemistry of CC3/TIP30 on breast tissue microarrays was also analyzed. Results: We have found that CC3/TIP30 expression is significantly associated with positive HER-2/neu status at both mRNA (P=0.023) and protein (P=0.016) levels. Immunohistochemical analysis on tissue microarrays also shows a positive correlation between CC3 expression and HER-2/neu status (P=0.0028). Conclusion: Our findings suggest a potential link between the expression of CC3/TIP30 gene and the HER-2/neu oncogene-mediated signal pathway.These findings could not have been predicted from previous experimental studies, and suggest that CC3/TIP30 may play a complex role in breast cancer.
引用
收藏
页码:603 / 608
页数:6
相关论文
共 18 条
[1]   Three-dimensional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression [J].
Baker, ME ;
Yan, L ;
Pear, MR .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (05) :851-858
[2]   C-erbB-2 in breast cancer: Development of a clinically useful marker [J].
Hayes, DF ;
Thor, AD .
SEMINARS IN ONCOLOGY, 2002, 29 (03) :231-245
[3]  
Hewitt RE, 2000, J PATHOL, V192, P455
[4]  
Ito M, 2003, CANCER RES, V63, P8763
[5]   TIP30 interacts with an estrogen receptor α-interacting coactivator CIA and regulates c-myc transcription [J].
Jiang, C ;
Ito, M ;
Piening, V ;
Bruck, K ;
Roeder, RG ;
Xiao, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :27781-27789
[6]   Inhibition of nuclear import by the proapoptotic protein CC3 [J].
King, FW ;
Shtivelman, E .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (16) :7091-7101
[7]   Systemic gene delivery expands the repertoire of effective antiangiogenic agents [J].
Liu, Y ;
Thor, A ;
Shtivelman, E ;
Cao, YH ;
Tu, GH ;
Heath, TD ;
Debs, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13338-13344
[8]   Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro [J].
NicAmhlaoibh, R ;
Shtivelman, E .
ONCOGENE, 2001, 20 (02) :270-275
[9]   Cell Signaling by Receptor Tyrosine Kinases [J].
Lemmon, Mark A. ;
Schlessinger, Joseph .
CELL, 2010, 141 (07) :1117-1134
[10]   A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma [J].
Shtivelman, E .
ONCOGENE, 1997, 14 (18) :2167-2173